PAUL D RUBIN Insider Trading $MGEN Viridian Therapeutics, Inc.\DE

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for PAUL D RUBIN.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of PAUL D RUBIN. PAUL D RUBIN is Sr. VP Clinical Dev. & CMO in XOMA Corp ($XOMA) and President and CEO in CORNERSTONE THERAPEUTICS INC ($CRTX) and EVP, Research & Development in MIRAGEN THERAPEUTICS, INC. ($SGNL).

PAUL D RUBIN in Viridian Therapeutics, Inc.\DE

Trading Symbol: MGEN
Industry: SERVICES-MEDICAL LABORATORIES [8071]
Position of PAUL D RUBIN: EVP, Research & Development
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 08 2019
$MGEN Market Capitalization: $9.56M
$MGEN Previous Close: $10.55

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of PAUL D RUBIN in Viridian Therapeutics, Inc.\DE

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, CRTX, MGEN, XOMA

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 08 2019MGENMIRAGEN THERAPEUTI ...RUBIN PAUL DEVP, Research & Dev ...Option ExerciseA2.9687,000257,52087,000
Feb 02 2018MGENMIRAGEN THERAPEUTI ...RUBIN PAUL DEVP, Research & Dev ...Option ExerciseA7.5085,000637,50085,000
Feb 16 2017SGNLMIRAGEN THERAPEUTI ...RUBIN PAUL DEVP, Research & Dev ...Option ExerciseA11.0187,500963,37587,500

Page:   1